• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶活性:膀胱冲洗液中膀胱移行细胞癌的潜在标志物。

Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.

作者信息

Yang S C, Lee D H, Hong S J, Chung B H, Kim I Y

机构信息

Department of Urology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Yonsei Med J. 1997 Jun;38(3):155-9. doi: 10.3349/ymj.1997.38.3.155.

DOI:10.3349/ymj.1997.38.3.155
PMID:9259615
Abstract

The enzyme telomerase maintains a constant telomere length in immortalized cells, allowing unlimited cell proliferation. Almost all cancer cells express telomerase activity. However, little data is available regarding the role of telomerase activity in the detection of bladder cancer with a bladder wash specimen. We detected telomerase activity in a bladder wash specimen of bladder cancer and normal tissues, and compared them with final pathologic diagnosis. Twenty-three patients with transitional cell carcinoma (TCC) of the bladder were enrolled in our study. A bladder wash specimen was obtained before transurethral resection of the bladder (TURB) and normal and cancer tissues from the same patients during TURB. Telomerase activity was analyzed in each specimen a using telomeric repeat amplification protocol (TRAP) assay based on polymerase chain reaction (PCR) technique. Cytologic diagnosis was performed using Papanicolaou's stain with cytocentrifuged cytology preparation. We observed telomerase activity in 95.7% (22/23) of bath cancer tissues and bladder wash specimens; only one case did not express telomerase activity. Telomerase activity was undetected in all normal tissues except one, which was obtained from a patient with carcinoma in situ. A total of 69.6% (16/23) of wash specimens were positive in cytopathologic diagnosis. The accuracy of cytopathologic diagnosis in pathologic grade 2 or 3 was relatively high (83.3%, 15/18). However, in five cases of grade 1 TCC only 20% (1/5) of cytologic diagnosis was positive whereas the telomerase activity of wash specimens was detected in 80% (4/5). Our data demonstrates that not only the majority of human bladder cancer tissues, but also the bladder wash specimens obtained from patients with TCC, expressed telomerase activity. It indicates that telomerase activity may be a reliable marker in detecting bladder cancer especially in cases with a low grade that bladder wash cytology can miss.

摘要

端粒酶可维持永生化细胞中端粒长度恒定,从而使细胞能够无限增殖。几乎所有癌细胞都表达端粒酶活性。然而,关于端粒酶活性在膀胱冲洗标本检测膀胱癌中的作用,目前可用数据较少。我们检测了膀胱癌及正常组织膀胱冲洗标本中的端粒酶活性,并将其与最终病理诊断结果进行比较。23例膀胱移行细胞癌(TCC)患者纳入本研究。在经尿道膀胱肿瘤切除术(TURB)前获取膀胱冲洗标本,并在TURB期间获取同一患者的正常组织和癌组织。使用基于聚合酶链反应(PCR)技术的端粒重复序列扩增法(TRAP)检测各标本中的端粒酶活性。采用巴氏染色法对细胞离心涂片进行细胞学诊断。我们观察到,95.7%(22/23)的膀胱癌组织和膀胱冲洗标本中存在端粒酶活性;仅1例未表达端粒酶活性。除1例原位癌患者的正常组织外,所有正常组织均未检测到端粒酶活性。细胞病理学诊断中,共有69.6%(16/23)的冲洗标本呈阳性。病理2级或3级的细胞病理学诊断准确性相对较高(83.3%,15/18)。然而,在5例1级TCC中,细胞学诊断阳性率仅为20%(1/5),而冲洗标本的端粒酶活性检测阳性率为80%(4/5)。我们的数据表明,不仅大多数人膀胱癌组织,而且TCC患者的膀胱冲洗标本也表达端粒酶活性。这表明端粒酶活性可能是检测膀胱癌的可靠标志物,尤其是在膀胱冲洗细胞学检查可能漏诊的低级别病例中。

相似文献

1
Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.端粒酶活性:膀胱冲洗液中膀胱移行细胞癌的潜在标志物。
Yonsei Med J. 1997 Jun;38(3):155-9. doi: 10.3349/ymj.1997.38.3.155.
2
Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.端粒酶:膀胱冲洗液中膀胱移行细胞癌的潜在标志物。
Clin Cancer Res. 1998 Mar;4(3):535-8.
3
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.评估端粒重复序列扩增法(TRAP)检测端粒酶作为复发性膀胱癌诊断方法的效果。
Clin Cancer Res. 1997 Sep;3(9):1593-8.
4
Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.膀胱癌患者尿液中脱落细胞端粒酶活性的检测
J Natl Cancer Inst. 1997 May 21;89(10):724-30. doi: 10.1093/jnci/89.10.724.
5
Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.人端粒酶逆转录酶信使核糖核酸与端粒酶活性作为膀胱癌尿液诊断标志物的比较
Mol Diagn. 2000 Dec;5(4):267-77. doi: 10.1007/BF03262087.
6
Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.人膀胱癌、膀胱冲洗液及尿液中端粒酶活性的非放射性检测
J Pathol. 1998 Jan;184(1):71-6. doi: 10.1002/(SICI)1096-9896(199801)184:1<71::AID-PATH988>3.0.CO;2-#.
7
Diagnosis of bladder cancer using telomerase activity in voided urine.利用排尿中的端粒酶活性诊断膀胱癌。
J Formos Med Assoc. 2000 Dec;99(12):920-5.
8
Telomerase activity in human bladder tumors and bladder washing specimens.人膀胱肿瘤及膀胱冲洗标本中的端粒酶活性
Kaohsiung J Med Sci. 2001 Dec;17(12):602-9.
9
Telomerase activity in diagnosis of bladder cancer.端粒酶活性在膀胱癌诊断中的应用
Scand J Urol Nephrol. 2003;37(3):205-9. doi: 10.1080/00365590310008055.
10
[Telomerase activity as marker of superficial tumor of the bladder].[端粒酶活性作为膀胱浅表肿瘤的标志物]
Arch Esp Urol. 2000 Apr;53(3):231-6.

引用本文的文献

1
Bladder tumor markers: need, nature and application. 1. Nucleus-based markers.膀胱肿瘤标志物:需求、性质及应用。1. 基于细胞核的标志物。
Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(4):221-7. doi: 10.1007/BF01901608.